TERESA MARSHALL: Open Payments
NPI 1104395482 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 12 payments from 11 companies in 2025. Trend: 2023 $231 · 2024 $806 · 2025 $1,440
Food & beverage: $1,440
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $243 |
| Abbott Laboratories | 1 | $163 |
| Organon LLC | 1 | $138 |
| Edwards Lifesciences Corporation | 1 | $125 |
| Novo Nordisk Inc | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| Madrigal Pharmaceuticals | 1 | $123 |
| GENZYME CORPORATION | 1 | $110 |
| Insmed, Inc. | 1 | $102 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
Products named: FREESTYLE LIBRE 3, VTAMA, Wegovy, AUSTEDO XR, REZDIFFRA, TEZSPIRE, DUPIXENT, Arikayce.
Industry payments across LA — which companies pay providers there.
